Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset (Preprint)
Preprint
- 28 February 2018
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Patients commonly transition between health care settings, requiring care providers to transfer medication utilization information. Yet, information sharing about adverse drug events (ADEs) remains nonstandardized. OBJECTIVE The objective of our study was to describe a minimum required dataset for clinicians to document and communicate ADEs to support clinical decision making and improve patient safety. METHODS We used mixed-methods analysis to design a minimum required dataset for ADE documentation and communication. First, we completed a systematic review of the existing ADE reporting systems. After synthesizing reporting concepts and data fields, we conducted fieldwork to inform the design of a preliminary reporting form. We presented this information to clinician end-user groups to establish a recommended dataset. Finally, we pilot-tested and refined the dataset in a paper-based format. RESULTS We evaluated a total of 1782 unique data fields identified in our systematic review that describe the reporter, patient, ADE, and suspect and concomitant drugs. Of these, clinicians requested that 26 data fields be integrated into the dataset. Avoiding the need to report information already available electronically, reliance on prospective rather than retrospective causality assessments, and omitting fields deemed irrelevant to clinical care were key considerations. CONCLUSIONS By attending to the information needs of clinicians, we developed a standardized dataset for adverse drug event reporting. This dataset can be used to support communication between care providers and integrated into electronic systems to improve patient safety. If anonymized, these standardized data may be used for enhanced pharmacovigilance and research activities.Keywords
All Related Versions
- Published version: JMIR Medical Informatics, 6 (2), e10248.
This publication has 13 references indexed in Scilit:
- Why Clinicians Don’t Report Adverse Drug Events: Qualitative StudyJMIR Public Health and Surveillance, 2018
- Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health recordSpringerPlus, 2016
- Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods DesignJMIR Research Protocols, 2016
- Adverse drug event reporting systems: a systematic reviewBritish Journal of Clinical Pharmacology, 2016
- Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic reviewTherapeutic Advances in Drug Safety, 2013
- Emergency Hospitalizations for Adverse Drug Events in Older AmericansNew England Journal of Medicine, 2011
- Ski hill injuries and ghost charts: Socio-technical issues in achieving e-Health interoperability across jurisdictionsInformation Systems Frontiers, 2011
- Recurrence of Adverse Drug Reactions following Inappropriate Re-PrescriptionDrug Safety, 2010
- Incidence, severity and preventability of medication-related visits to the emergency department: a prospective studyCanadian Medical Association Journal, 2008
- Represcription After Adverse Drug Reaction in the Elderly: A Descriptive StudyArchives of internal medicine (1960), 2006